| Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds N Sundahl, J Bridelance, C Libert, K De Bosscher, IM Beck Pharmacology & therapeutics 152, 28-41, 2015 | 235 | 2015 |
| Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma N Sundahl, G Vandekerkhove, K Decaestecker, A Meireson, ... European urology 75 (5), 707-711, 2019 | 104 | 2019 |
| Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer G Vandekerkhove, JM Lavoie, M Annala, AJ Murtha, N Sundahl, S Walz, ... Nature Communications 12 (1), 184, 2021 | 100 | 2021 |
| Very late xerostomia, dysphagia, and neck fibrosis after head and neck radiotherapy M Baudelet, L Van den Steen, P Tomassen, K Bonte, P Deron, ... Head & neck 41 (10), 3594-3603, 2019 | 85 | 2019 |
| Radiomics to predict outcomes and abscopal response of patients with cancer treated with immunotherapy combined with radiotherapy using a validated signature of CD8 cells R Sun, N Sundahl, M Hecht, F Putz, A Lancia, A Rouyar, M Milic, A Carré, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 56 | 2020 |
| Effects of radiation on the metastatic process N Sundahl, F Duprez, P Ost, W De Neve, M Mareel Molecular Medicine 24, 1-20, 2018 | 53 | 2018 |
| Phase 2 trial of nivolumab combined with stereotactic body radiation therapy in patients with metastatic or locally advanced inoperable melanoma N Sundahl, T Seremet, J Van Dorpe, B Neyns, L Ferdinande, A Meireson, ... International Journal of Radiation Oncology* Biology* Physics 104 (4), 828-835, 2019 | 49 | 2019 |
| A systematic review of exercise and psychosocial rehabilitation interventions to improve health-related outcomes in patients with bladder cancer undergoing radical cystectomy E Rammant, K Decaestecker, R Bultijnck, N Sundahl, P Ost, NS Pauwels, ... Clinical rehabilitation 32 (5), 594-606, 2018 | 44 | 2018 |
| Medical emergencies related to ethanol and illicit drugs at an annual, nocturnal, indoor, electronic dance music event P Calle, N Sundahl, K Maudens, SMR Wille, D Van Sassenbroeck, ... Prehospital and disaster medicine 33 (1), 71-76, 2018 | 36 | 2018 |
| Combined high dose radiation and pazopanib in metastatic renal cell carcinoma: a phase I dose escalation trial K De Wolf, S Rottey, K Vermaelen, K Decaestecker, N Sundahl, ... Radiation oncology 12, 1-8, 2017 | 35 | 2017 |
| Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma L Brochez, A Meireson, I Chevolet, N Sundahl, P Ost, V Kruse Nature communications 9 (1), 2921, 2018 | 34 | 2018 |
| Combining high dose external beam radiotherapy with a simultaneous integrated boost to the dominant intraprostatic lesion: analysis of genito-urinary and rectal toxicity N Sundahl, G De Meerleer, G Villeirs, P Ost, W De Neve, N Lumen, ... Radiotherapy and Oncology 119 (3), 398-404, 2016 | 33 | 2016 |
| Phase 1 dose escalation trial of ipilimumab and stereotactic body radiation therapy in metastatic melanoma N Sundahl, K De Wolf, V Kruse, A Meireson, D Reynders, E Goetghebeur, ... International Journal of Radiation Oncology* Biology* Physics 100 (4), 906-915, 2018 | 32 | 2018 |
| A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response K De Wolf, V Kruse, N Sundahl, M Van Gele, I Chevolet, R Speeckaert, ... Journal of translational medicine 15, 1-6, 2017 | 30 | 2017 |
| A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and … N Sundahl, K De Wolf, S Rottey, K Decaestecker, D De Maeseneer, ... Journal of translational medicine 15, 1-9, 2017 | 29 | 2017 |
| Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments N Sundahl, D Clarisse, M Bracke, F Offner, WV Berghe, IM Beck Oncoscience 3 (7-8), 188, 2016 | 28 | 2016 |
| When What You See Is Not Always What You Get: Raising the Bar of Evidence for New Diagnostic Imaging Modalities. N Sundahl, S Gillessen, C Sweeney, P Ost European urology 79 (5), 565-567, 2020 | 27 | 2020 |
| Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma SGC Kroeze, C Fritz, J Schaule, S Siva, KH Kahl, N Sundahl, O Blanck, ... BJU international 127 (6), 703-711, 2021 | 23 | 2021 |
| Inter-professional collaboration reduces the burden of caring for patients with mental illnesses in primary healthcare. A realist evaluation study M De Sutter, A De Sutter, N Sundahl, T Declercq, P Decat European Journal of General Practice 25 (4), 236-242, 2019 | 19 | 2019 |
| Mental health and quality of life among patients with cancer during the SARS-CoV-2 pandemic: results from the longitudinal ONCOVID survey study EA De Jaeghere, H Kanervo, R Colman, W Schrauwen, P West, ... Cancers 14 (4), 1093, 2022 | 17 | 2022 |
